(ZIVO) Zivo Bioscience - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US98978N2009
Algae, Bioactive Ingredients, Animal Feed, Human Supplements, Medical Food
ZIVO EPS (Earnings per Share)
ZIVO Revenue
Description: ZIVO Zivo Bioscience
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan., Web URL: https://www.zivobioscience.com
Additional Sources for ZIVO Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
ZIVO Stock Overview
| Market Cap in USD | 46m |
| Sector | Healthcare |
| Industry | Biotechnology |
| GiC Sub-Industry | Personal Care Products |
| IPO / Inception | 2012-09-24 |
ZIVO Stock Ratings
| Growth Rating | 53.8 |
| Fundamental | - |
| Dividend Rating | 0.0 |
| Rel. Strength | 68.8 |
| Analysts | 3 of 5 |
| Fair Price Momentum | 11.69 USD |
| Fair Price DCF | - |
ZIVO Dividends
Currently no dividends paidZIVO Growth Ratios
| Growth Correlation 3m | -45.4% |
| Growth Correlation 12m | 25.1% |
| Growth Correlation 5y | 14.9% |
| CAGR 5y | 87.61% |
| CAGR/Max DD 5y | 0.89 |
| Sharpe Ratio 12m | -0.03 |
| Alpha | 67.62 |
| Beta | 0.961 |
| Volatility | 252.15% |
| Current Volume | 0.2k |
| Average Volume 20d | 0.1k |
| Stop Loss | 12.4 (-8.1%) |
What is the price of ZIVO shares?
As of July 12, 2025, the stock is trading at USD 13.50 with a total of 200 shares traded.
Over the past week, the price has changed by +3.85%, over one month by -3.50%, over three months by -10.00% and over the past year by +58.82%.
As of July 12, 2025, the stock is trading at USD 13.50 with a total of 200 shares traded.
Over the past week, the price has changed by +3.85%, over one month by -3.50%, over three months by -10.00% and over the past year by +58.82%.
Is Zivo Bioscience a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Zivo Bioscience (NASDAQ:ZIVO) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 53.80 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ZIVO is around 11.69 USD . This means that ZIVO is currently overvalued and has a potential downside of -13.41%.
Partly, yes. Based on ValueRay´s Analyses, Zivo Bioscience (NASDAQ:ZIVO) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 53.80 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ZIVO is around 11.69 USD . This means that ZIVO is currently overvalued and has a potential downside of -13.41%.
Is ZIVO a buy, sell or hold?
Zivo Bioscience has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold ZIVO.
Zivo Bioscience has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold ZIVO.
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts for ZIVO share price target?
According to our own proprietary Forecast Model, ZIVO Zivo Bioscience will be worth about 13.7 in July 2026. The stock is currently trading at 13.50. This means that the stock has a potential upside of +1.26%.
According to our own proprietary Forecast Model, ZIVO Zivo Bioscience will be worth about 13.7 in July 2026. The stock is currently trading at 13.50. This means that the stock has a potential upside of +1.26%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12 | -11.1% |
| Analysts Target Price | 12 | -11.1% |
| ValueRay Target Price | 13.7 | 1.3% |